12 Biggest Mid-Day Losers For Monday

Ekso Bionics Holdings, Inc. EKSO shares dropped 19.2 percent to $3.32 after the company reported the pricing of its $11.7 million financing.
DryShips Inc. DRYS shares tumbled 18.8 percent to $1.34 after the company disclosed that it has entered into a $226.4 million stock purchase agreement with Kalani Investments and agreed to acquire 6 vessels for a total gross price of $268 million.
Akoustis Technologies Inc AKTS declined 14 percent to $11.04.
TearLab Corp TEAR shares dropped 13.7 percent to $2.45.
Orexigen Therapeutics, Inc. OREX shares fell 13.4 percent to $2.98.
Akari Therapeutics PLC (ADR) AKTX shares declined 13 percent to $9.63.
Diffusion Pharmaceuticals Inc DFFN dipped 10.5 percent to $3.57 as the company reported the closing of oversubscribed private placement.
Acorda Therapeutics Inc ACOR shares declined 6.7 percent to $19.60 after dropping 21.50 percent on Friday.
United Therapeutics Corporation UTHR shares fell 6 percent to $127.34 after the company disclosed that the US launch of RemoSynch will be delayed due to regulatory delays.
Rewalk Robotics Ltd RWLK dropped 4 percent to $2.02. Barclays downgraded Rewalk Robotics from Equal-Weight to Underweight.
Forward Pharma A/S FWP declined 4 percent to $20.68. Jefferies downgraded Forward Pharma from Buy to Hold.
Accenture Plc ACN fell 2 percent to $117.63. Goldman Sachs downgraded Accenture from Neutral to Sell and lowered the price target from $125.00 to $110.00.